BioCryst(BCRX)
$7.50+0.05 (+0.67%)
BCRX
BioCryst financials statements
$7.50
At close:+0.05 (+0.67%)
Want to see BCRX full AI Analyst Report?
BioCryst (BCRX) Ratios
2,783 Followers
BioCryst Ratios
BCRX's free cash flow for Q3 2026 was $32.75M. For the 2026 fiscal year, BCRX's free cash flow was decreased by $-233.00K and operating cash flow was $32.98M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.06 | 2.63 | 3.31 | 4.90 | 5.46 |
| Quick Ratio | 2.03 | 2.58 | 3.12 | 4.63 | 5.31 |
| Cash Ratio | 0.46 | 0.65 | 0.74 | 2.89 | 4.86 |
| Solvency Ratio | 0.42 | -0.09 | -0.23 | -0.29 | -0.26 |
| Operating Cash Flow Ratio | 1.68 | -0.32 | -0.63 | -1.53 | -1.37 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -1.47 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -228.97M | $ -544.39M | $ -476.52M | $ -328.10M | $ -129.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.85 | 1.72 | 1.60 | 1.35 | 1.01 |
| Debt-to-Equity Ratio | -3.68 | -1.77 | -1.81 | -2.52 | -5.55 |
| Debt-to-Capital Ratio | 1.37 | 2.30 | 2.23 | 1.66 | 1.22 |
| Long-Term Debt-to-Capital Ratio | 1.39 | 2.49 | 2.28 | 1.67 | 1.22 |
| Financial Leverage Ratio | -4.32 | -1.03 | -1.13 | -1.87 | -5.50 |
| Debt Service Coverage Ratio | 4.36 | 0.08 | -1.08 | -1.48 | -2.09 |
| Interest Coverage Ratio | 4.32 | -0.03 | -0.96 | -1.50 | -3.00 |
| Debt to Market Cap | 0.26 | 0.53 | 0.70 | 0.34 | 0.24 |
| Interest Debt Per Share | 2.47 | 4.55 | 4.86 | 4.52 | 3.64 |
| Net Debt to EBITDA | 1.00 | 57.50 | -6.14 | -3.04 | -0.73 |
| Profitability Margins | |||||
| Gross Profit Margin | 97.82% | 97.23% | 98.59% | 97.57% | 95.38% |
| EBIT Margin | 39.58% | 2.57% | -35.60% | -53.65% | -77.95% |
| EBITDA Margin | 39.74% | 2.84% | -35.10% | -53.12% | -77.46% |
| Operating Profit Margin | 38.98% | -0.56% | -31.29% | -54.81% | -113.08% |
| Pretax Profit Margin | 30.56% | -19.29% | -68.26% | -90.24% | -115.68% |
| Net Profit Margin | 30.16% | -19.72% | -68.36% | -91.24% | -117.11% |
| Continuous Operations Profit Margin | 30.16% | -19.72% | -68.36% | -91.24% | -117.11% |
| Net Income Per EBT | 98.68% | 102.22% | 100.14% | 101.12% | 101.24% |
| EBT Per EBIT | 78.42% | 3419.35% | 218.14% | 164.64% | 102.30% |
| Return on Assets (ROA) | 51.32% | -18.12% | -43.82% | -44.93% | -31.30% |
| Return on Equity (ROE) | -221.45% | 18.68% | 49.73% | 83.88% | 172.04% |
| Return on Capital Employed (ROCE) | 107.20% | -0.77% | -28.26% | -33.39% | -36.69% |
| Return on Invested Capital (ROIC) | 105.24% | -0.70% | -28.06% | -33.22% | -36.55% |
| Return on Tangible Assets | 51.32% | -18.12% | -43.82% | -44.93% | -31.30% |
| Earnings Yield | 16.12% | -5.72% | -19.68% | -11.58% | -7.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.19 | 5.70 | 5.82 | 5.35 | 5.34 |
| Payables Turnover | 1.21 | 1.07 | 0.22 | 0.46 | 0.26 |
| Inventory Turnover | 3.53 | 1.54 | 0.16 | 0.24 | 0.46 |
| Fixed Asset Turnover | 46.08 | 22.78 | 15.85 | 31.43 | 10.35 |
| Asset Turnover | 1.70 | 0.92 | 0.64 | 0.49 | 0.27 |
| Working Capital Turnover Ratio | 3.72 | 1.48 | 0.88 | 0.62 | 0.46 |
| Cash Conversion Cycle | -154.97 | -39.96 | 672.75 | 797.58 | -535.52 |
| Days of Sales Outstanding | 44.57 | 64.03 | 62.72 | 68.19 | 68.31 |
| Days of Inventory Outstanding | 103.29 | 236.42 | 2246.15 | 1524.04 | 793.46 |
| Days of Payables Outstanding | 302.83 | 340.41 | 1636.12 | 794.65 | 1397.29 |
| Operating Cycle | 147.86 | 300.46 | 2308.87 | 1592.24 | 861.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.57 | -0.25 | -0.50 | -0.87 | -0.79 |
| Free Cash Flow Per Share | 1.56 | -0.26 | -0.51 | -0.88 | -0.81 |
| Dividend Paid and CapEx Coverage Ratio | 133.66 | -46.28 | -43.88 | -119.80 | -59.60 |
| Capital Expenditure Coverage Ratio | 133.66 | -46.28 | -43.88 | -119.80 | -59.60 |
| Operating Cash Flow Coverage Ratio | 0.75 | -0.06 | -0.12 | -0.22 | -0.24 |
| Operating Cash Flow to Sales Ratio | 0.38 | -0.12 | -0.29 | -0.60 | -0.90 |
| Free Cash Flow Yield | 20.00% | -3.42% | -8.45% | -7.65% | -5.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.19 | -17.49 | -5.08 | -8.64 | -13.48 |
| Price-to-Sales (P/S) Ratio | 1.87 | 3.45 | 3.47 | 7.88 | 15.78 |
| Price-to-Book (P/B) Ratio | -13.74 | -3.27 | -2.53 | -7.24 | -23.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.00 | -29.25 | -11.83 | -13.08 | -17.16 |
| Price-to-Operating Cash Flow Ratio | 4.96 | -29.88 | -12.10 | -13.19 | -17.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.02 | 0.28 | 0.45 | -0.30 | 2.45 |
| Enterprise Value Multiple | 5.71 | 178.86 | -16.04 | -17.87 | -21.11 |
| Enterprise Value | 1.99B | 2.29B | 1.87B | 2.57B | 2.57B |
| EV to EBITDA | 5.71 | 178.86 | -16.04 | -17.87 | -21.11 |
| EV to Sales | 2.27 | 5.08 | 5.63 | 9.49 | 16.35 |
| EV to Free Cash Flow | 6.07 | -43.11 | -19.17 | -15.75 | -17.78 |
| EV to Operating Cash Flow | 6.02 | -44.04 | -19.61 | -15.88 | -18.08 |
| Tangible Book Value Per Share | -0.57 | -2.30 | -2.37 | -1.58 | -0.60 |
| Shareholders’ Equity Per Share | -0.57 | -2.30 | -2.37 | -1.58 | -0.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.02 | -0.00 | -0.01 | -0.01 |
| Revenue Per Share | 4.17 | 2.18 | 1.72 | 1.46 | 0.88 |
| Net Income Per Share | 1.26 | -0.43 | -1.18 | -1.33 | -1.03 |
| Tax Burden | 0.99 | 1.02 | 1.00 | 1.01 | 1.01 |
| Interest Burden | 0.77 | -7.52 | 1.92 | 1.68 | 1.48 |
| Research & Development to Revenue | 0.19 | 0.39 | 0.65 | 0.94 | 1.33 |
| SG&A to Revenue | 0.40 | 0.59 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.10 | 0.15 | 0.17 | 0.17 | 0.22 |
| Income Quality | 1.25 | 0.59 | 0.42 | 0.65 | 0.77 |
Currency in USD

